Scientists Discover New Drug Target To Prevent Alzheimer's

Scientists at the Flanders Institute for Biotechnology (VIB) claim that they have discovered a potential therapeutic target for Alzheimer's disease.

The team led by Amantha Thathiah, in collaboration with researchers from the biotech company Galapagos, have identified a protein called GPR3, which plays a key role in plaque build-up in the brain.

Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.

While experimenting on mice, the researchers observed that blocking GPR3 led to a reduction of the plaques.

The brains of Alzheimer's patients typically show the presence of amyloid plaques, which are abnormal accumulations of a protein (ß-amyloid) between the neurons.

Current medicines for Alzheimer's patients sustain the memory functions for a short time, but they are unable to stop the brain cells from dying off.

Diseases Related to Old Age
Ageing is referred to the accumulation of changes that brings a person closer to death.

They are able to limit the loss of memory during the early phases of the disease.

The GPR3 protein is an important target molecule for the eventual development of a new medicine against Alzheimer's disease.

Brilliant Human Brain
The most amazing and complex organ in the entire universe, the human brain continues to remain an enigma.

Source-ANI
SRM

Stroke Drug Enhances Memory, Lowers Alzheimer's Risk
A drug used to improve blood flow to the brain also could help reduce the risk of Alzheimer's disease, according to a new study.